H Brincker
-
- Lymphoma Diagnosis and Treatment 21
- Oncology top 2%
- Cancer Treatment and Pharmacology 11
- Hematology top 2%
- Acute Myeloid Leukemia Research 11
- Physiology top 2%
- Sarcoidosis and Beryllium Toxicity Research 12
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 8
-
- Breast Cancer Treatment Studies 10
-
- Acute Lymphoblastic Leukemia research 9
-
- CNS Lymphoma Diagnosis and Treatment 8
H Brincker
92 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 106
- Pathology and Forensic Medicine 1.0k
- Oncology 1.3k
- Hematology 372
- Physiology 852
- Pulmonary and Respiratory Medicine 1.0k
Countries citing papers authored by H Brincker
This map shows the geographic impact of H Brincker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Brincker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Brincker more than expected).
Fields of papers citing papers by H Brincker
This network shows the impact of papers produced by H Brincker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Brincker. The network helps show where H Brincker may publish in the future.
Co-authorship network
The 25 scholars most cited alongside H Brincker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 143 | |
| 2 | 1999 | 18 | |
| 3 | 1998 | 42 | |
| 4 | 1998 | 83 | |
| 5 | 1994 | 241 | |
| 6 | 1993 | 32 | |
| 7 | 1993 | 18 | |
| 8 | 1993 | 36 | |
| 9 | 1992 | 38 | |
| 10 | 1992 | 85 | |
| 11 | 1992 | 19 | |
| 12 | 1991 | 6 | |
| 13 | 1991 | 15 | |
| 14 | 1991 | 154 | |
| 15 | 1989 | 8 | |
| 16 | 1989 | 22 | |
| 17 | 1988 | 26 | |
| 18 | 1988 | 11 | |
| 19 | 1987 | 8 | |
| 20 | Development of pulmonary aspergillomas coinciding with induction of remission in acute myeloid leukaemia. | 1974 | 8 |
About H Brincker
H Brincker is a scholar working on Pathology and Forensic Medicine, Oncology, Hematology, Genetics and Pulmonary and Respiratory Medicine, having authored 93 papers that have together received 3.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (21 papers), Sarcoidosis and Beryllium Toxicity Research (12 papers), Acute Myeloid Leukemia Research (11 papers), Cancer Treatment and Pharmacology (11 papers), Breast Cancer Treatment Studies (10 papers), Acute Lymphoblastic Leukemia research (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and CNS Lymphoma Diagnosis and Treatment (8 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.0k citations), Oncology (1.3k citations), Hematology (372 citations), Physiology (852 citations) and Pulmonary and Respiratory Medicine (1.0k citations). H Brincker has collaborated with scholars based in Denmark, United Kingdom and Finland. Frequent co-authors include E Wilbek, Francesco d’Amore, Niels T. Pedersen, K Thorling, Gunnar Sæter, M. G. Pedersen, Bjarne Christensen, Elo Andersen, Leif Spange Mortensen and Morten K. Jensen. Their work appears in journals such as Acta Oncologica, British Journal of Cancer, British Journal of Haematology, Annals of Oncology and Mycoses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.